Array BioPharma Investigative Site
Amsterdam 1066 CX
0 studies enrolling now · 1 studies all time
What they study most
Metastatic Colorectal Cancer
Studies at this site
Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations
— Completed